Platinum analogs as potential new drugs for bladder cancer.
D016190:Carboplatin; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D009944:Organoplatinum Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy*
D009944:Organoplatinum Compounds; C023359:iproplatin; C021967:carboxyphthalato-1,2-diaminocyclohexaneplatinum; D016190:Carboplatin; C040757:spiroplatin